[Federal Register: February 1, 2002 (Volume 67, Number 22)]
[Notices]
[Page 4988-4989]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01fe02-82]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Best Practices for Reducing Transfusion Errors; Public Workshop
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing the following
public workshop: Best Practices for Reducing Transfusion Errors. The
purpose of the public workshop is to discuss practices and techniques
that may decrease transfusion errors, including systems and technology
that can be applied to reducing transfusion errors.
Date and Time: The public workshop will be held on February 14,
2002, from 8:30 a.m. to 5 p.m., and February 15, 2002, from 8:30 a.m.
to 12:30 p.m.
Location: The public workshop will be held at the Natcher
Conference Center, National Institutes of Health, Bldg. 45, 45 Center
Dr., 8600 Rockville Pike, Bethesda, MD.
Contact: Joseph Wilczek, Center for Biologics Evaluation and
Research (HFM-302), Food and Drug Administration, 1401 Rockville Pike,
Rockville, MD 20852-1448, 301-827-6129, FAX 301-827-2843.
Registration: Send registration information (including name, title,
firm name, address, telephone, and fax number) to the contact person by
February 5, 2002. Onsite registration on a space available basis will
begin at 7:30 a.m. on the days of the workshop. There is no
registration fee. If you need special accommodations due to a
disability, please contact Joseph Wilczek at least 7 days in advance.
Transcripts: Transcripts of the public workshop may be requested in
writing from the Freedom of Information Office (HFI-35), Food and Drug
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857,
approximately 15 working days after the meeting at a cost of 10 cents
per page. The public workshop transcript will also be available on the
Internet at
http://www.fda.gov/cber/minutes/workshop-min.htm.
SUPPLEMENTARY INFORMATION: FDA and the Agency for Healthcare Research
and Quality, Department of Health and Human Services, are cosponsoring
a public workshop on avoiding errors in transfusion medicine. On the
first day of the workshop, topics to be discussed include: Patient and
medication identification, errors in manufacturing and testing of blood
and blood components, system errors and cultural factors, and the role
of product deviation reporting in reducing transfusion errors. The
second day of the workshop will address current as well as future
technology trends that should help prevent transfusion errors. The
public workshop agenda is posted on the Internet at http://www.fda.gov/
cber/meetings/trnfsnerr021402.htm.
[[Page 4989]]
Dated: January 28, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-2550 Filed 1-31-02; 8:45 am]
BILLING CODE 4160-01-S